Mikhail Blagosklonny is well renowned in the field of research. His advancement of therapies can be considered as a breakthrough as these have helped to alleviate pain as well as suffering amongst those who are suffering from cancer. Recently, Mikhail Blagosklonny has proposed using of Rapamycin as he considers this drug to be effective in order to slow down the process of aging. This is something that people are making a note of as Dr. Mikhail Blagosklonny commands authority in the sectors of cancer as well as aging.He has always been a great proponent of Rapamycin. This is a cancer treatment medication that is highly popular. He believes that this drug eases the pain and suffering of cancer patients besides extending their lifespan too. Based on this, Mikhail Blagosklonny believes that this drug can boost the immune system of humans in a successful manner. This will help in enhancing longevity in them.
- Mikhail Blagosklonny states that Rapamycin can slow down aging as it has the ability to inhibit mTOR. This is a chemical compound found in the body. Its production tends to enhance with age. This is not a harmful compound. But it is required only when the human body is in the development stage. Later on, it tends to promote the process of aging besides leading to several other health complications too.
Rapamycin will help in slowing down the aging process besides strengthening the immunity of the human body too. This will help to delay the onset of several illnesses which accompany aging. Cancerous infections are one of them. This way the drug can help in prolonging life.Mikhail Blagosklonny is making these statements based on the research that has been done on animals that have been treated by making use of Rapamycin. Such animals live longer than those who were not treated with this drug. Hence it is a clear indication that Rapamycin can extend human life.This drug acts by inactivating those genes which tend to enhance the aging rate among human beings. Besides, it helps to suppress cellular senescence. This is a hormone that contributes to aging in a big way. In addition, it helps in preventing Parkinson’s disease along with Alzheimer’s. Both these diseases are associated with aging.
Currently, Rapamycin is being used for cancer treatment only. But such kind of research by Oncotarget will ensure that it is used for several other purposes very soon in the coming years.Mikhail Blagosklonny is a highly passionate cancer researcher. His contribution to oncology cannot be ignored. This is why he is considered as an asset to the pharmaceutical as well as medical field. His research has helped millions of cancer patients to gain access to cancer treatment that is affordable as well as effective too.Currently, he is working at Roswell Park Cancer Institute. This is a prominent facility that promotes cancer therapies. He is a professor of oncology at this institution. In addition, he is leading many research teams.